Search Ontology:
ChEBI
alpha-KDN-(2->3)-beta-D-Galp-(1->3)-beta-D-GlcpNAc
- Term ID
- CHEBI:71438
- Synonyms
-
- (6R)-3-deoxy-6-[(1R,2R)-1,2,3-trihydroxypropyl]-beta-L-threo-hex-2-ulopyranonosyl-(2->3)-beta-D-galactopyranosyl-(1->3)-2-acetamido-2-deoxy-beta-D-glucopyranose
- 3-deoxy-D-glycero-alpha-D-galacto-non-2-ulopyranosonyl-(2->3)-beta-D-galactopyranosyl-(1->3)-2-acetamido-2-deoxy-beta-D-glucopyranose
- alpha-KDN-(2->3)-beta-D-Gal-(1->3)-beta-D-GlcNAc
- deamino-alpha-neuraminyl-(2->3)-beta-D-galactosyl-(1->3)-N-acetyl-beta-D-glucosamine
- KDNa2-3Galb1-3GlcNAcb
- KDNalpha2-3Galbeta1-3GlcNAcbeta
- O-3-deoxy-D-glycero-alpha-D-galacto-2-nonulopyranonosyl-(2->3)-O-beta-D-galactopyranosyl-(1->3)-2-(acetylamino)-2-deoxy-beta-D-glucopyranose
- Definition
- A linear amino trisaccharide consisting of alpha-KDN, beta-D-galactose and N-acetyl-beta-D-glucosamine residues linked sequentially (2->3) and (1->3).
- References
- Ontology
- ChEBI ( EBI )
- is a type of
-
- has_role
-
Phenotype
Phenotype resulting from alpha-KDN-(2->3)-beta-D-Galp-(1->3)-beta-D-GlcpNAc
Phenotype where environments contain alpha-KDN-(2->3)-beta-D-Galp-(1->3)-beta-D-GlcpNAc
Phenotype modified by environments containing alpha-KDN-(2->3)-beta-D-Galp-(1->3)-beta-D-GlcpNAc
Human Disease Model